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TECHNICAL NOTE
A new method for monitoring body fluid variation by
bioimpedance analysis: The RXc graph
ANTONIO PICcOLI, BARBARA Rossi, LUANA PILLON, and GIUSEPPE BUCCIANTE
Institute of Internal Medicine, Division of Nephrology, and Clinical Nutrition Uni4 University of Padova, Padova, Italy
Bioelectrical impedance analysis (BIA) is a safe, noninvasive,
rapid, reproducible, portable and inexpensive method using sim-
ple equations for safely and accurately estimating the total body
water with a correlation coefficient of 0.996, and 1.67 kg standard
error of estimate [1, 2]. BIA-derived equations, validated in a
healthy population, produce biased estimates of compartment
volumes in patients with fluid overloading, or with dehydration,
since formulae are necessarily bound to normal body weight and
composition [3]. Due to the shape of the pressure-volume curve of
the interstitial fluid spaces, edema is not usually detectable until
the interstitial fluid volume has risen to about 30% (4 to 5 liters)
above normal [4]. The literature does not provide any cut-off value
for BIA measurements in the bedside identification of the indi-
vidual patient's fluid status [3], either with fluid overload before
the appearance of edema or with dehydration before clinical signs.
However, both components of the impedance vector Z, namely
resistance (R) and reactance (Xc), separately considered, corre-
lated highly with net fluid balance in cardiac patients after surgery
[5], and in the rehydration of cholera patients [6].
In this study, we present a new approach for routine monitoring
of the body fluid variation in the single patient, without making
any assumption on body composition. The method is based on the
analysis of the bivariate distribution of the impedance vector in a
healthy population and in patients with increased body weight,
due to either obesity or edema from renal diseases.
Methods
To validate the new method, we studied a total of 217 adult
caucasian subjects who gave informed consent. Subjects were
divided into four classification groups: 86 healthy control subjects
(CS) (38 males, 48 females, age 16 to 66 years), 55 patients (31
males, 24 females, age 18 to 75 years) with mild to terminal
chronic renal failure (CRF) in conservative treatment (serum
creatinine 124 to 1912 LLmol/liter (1.4 to 21.6 mg/dl)), with
undetectable to severe edema (15% with apparent edema), 36
patients (19 males, 17 females, age 16 to 75 years) with idiopathic
nephrotic syndrome (NS) (proteinuria from 3.5 to 23 glday; 28%
in the interval 3.5 to 5 g/day, 39% in the interval 5 to 10 g/day, and
33% in the interval 10 to 23 glday), with undetectable to severe
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edema (58% with apparent edema), and 40 obese subjects (OS) (9
males, 31 females, age 24 to 71 years) with body mass index (BMI)
higher than 31 kglm2, free from diabetes, kidney, heart and liver
diseases.
All subjects had height (H), weight, BMI, and BIA determined
on the same day. Serum creatinine, total protein, albumin, Na,
and urinary protein concentrations were determined according to
standard laboratory methods. Oncotic pressure was estimated
from serum total protein and albumin concentrations according to
Miller and Meyer [7]. BIA was performed with an impedance
plethysmograph, which emitted 800 1sA and 50 kHz alternating
sinusoidal current (model BIA-109 RJL/Akern Systems, Detroit,
Michigan, USA) and was connected to surface electrodes (stan-
dard, tetrapolar placement on the right hand and foot) strictly
following the method reported elsewhere [5, 6, 81. The two
components of the whole-body impedance vector, R and Xc, were
recorded from single representative stable measurements, con-
ducted by the same operator. We standardized BIA measure-
ments by the H of subjects, thus expressing both RIH and Xc/H in
Ohm/m. The mean coefficient of variation was 1% for within-day
and 3% for weekly intraindividual measurements in the steady
state condition, and 2% for the interoperator variability (ito 2 cm
displacement of electrodes from the anatomical reference points).
Differences in mean values of protocol variables among groups
were assessed by the two-way analysis of variance (ANOVA, F
test), considering sex and disease groups as classification criteria.
Relationships between variables were assessed by linear correla-
tion analysis (r coefficient). The programs of the statistical pack-
age BMDP [9] were used for calculations.
Assuming the bivariate normal distribution [10] of R/H and
Xc/H, we calculated the bivariate 95% confidence limits (Appen-
dix) for mean impedance vectors of the different classification
groups (that is, the ellipse, within which the two-dimensional
mean vectors fall with a 95% probability; Fig. 1). We called the
"RXc mean graph" the average of RIH and Xc/H, recorded in
groups of patients and plotted on the 95% confidence ellipse for
the healthy population (Figs. 1 and 2). For the evaluation of the
individual patient's vector, we calculated the bivariate 75% and
95% tolerance limits (Appendix) of the reference vector (that is,
the ellipses for the healthy population, within which the vector of
the individual subject falls with a probability of 75% and 95%,
respectively; Fig. 3). The "RXc point graph" was defined as a
single measurement of the two height-standardized components
of the impedance vector, namely R/H and Xe/H, recorded in the
individual patient and plotted on the reference, 75% and 95%
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10 Fig. 1. "RXc mean graph" with the 95%
confidence ellipses for males (A) and females (B)
of the classification groups. Symbols are: ()
CS, healthy control subjects, (0) CRF, chronic
renal failure, (0) NS, nephrotic syndrome, ()
OS, obese subjects). R is the resistance, Xc the
reactance, and H the height.
Fig. 2. "RXc mean graph" with data drawn from
literature and plotted over the sex-specific 95%
confidence ellipse for our healthy population. Left
panel vectors are: athletes [17], cholera [6]
[admission with dehydration (A), first 24 hours
of rehydration (B), 10th day hydration (C)],
surgery [5] [leaving the preoperative day (a),
fluid infusions moved the vector back on the
first postoperative day (b), and on the 7th day
the mean vector returned to the baseline (c)J,
AIDS [18], and ascites [14]. Right panel vectors
are: athletes [17], obese before and after short-
term fasting [16], cholera [6] (as in left panel)
and anorexia nervosa [19]. R is the resistance,
Xc the reactance, and H the height.
tolerance ellipses for the healthy population (Fig. 3). The "RXc
path graph" was defined as the walk of the successive point
measurements of the impedance vector, recorded over a follow-up
period in the same subject, and plotted over the reference 75%
and 95% tolerance ellipses for the healthy population (Fig. 4).
Results
Results considering the disease group and gender are reported
in Table 1 and Figure 1. With respect to the CS group vector, a
shorter impedance vector was demonstrated in both obese and
renal patients, without any overlapping of confidence ellipses
(that is, average vectors with a phase angle significantly greater in
OS and significantly smaller in renal patients; Fig. 1). The 95%
confidence ellipses of the two renal patient groups were overlap-
ping in both males and females (that is, no significant vector
displacement).
The two components of the impedance vector, R/H and Xc/H,
were significantly and linearly correlated in all groups considered,
either as a whole or by sex, with apparently lower r values in the
CS group (Table 2), which was reflected by the shape (relation
between the major and minor axis) of confidence and tolerance
ellipses (Figs. 1 and 3, respectively). R/H and Xe/H were not
significantly correlated with age in the CS group, as a whole or by
sex (absolute r values less than 0.15 and 0.23, respectively).
Therefore, we did not plot the set of (overlapping) tolerance
ellipses by sex and age classes for the reference impedance vector.
We found that disease and sex had a significant effect on the
means of both R/FI and Xe/H (Table 1) using the conventional
univariate analysis (two-way ANOVA). There was no significant
interaction between sex and disease classification for R/H nor for
Xe/H (Table 1). The same results were found considering non-
standardized R and Xc measurements (data not reported).
To find operative cut-off percentiles of the bivariate distribution
for the impedance vector, we plotted the impedance vector of
single patients over the sex-specific reference tolerance ellipses
(95th and 75th percentile) for the healthy population (Fig. 3). No
obese subject fell out of the 95% tolerance ellipse. No renal
patient fell out of the upper poles of either 95% and 75%
tolerance ellipses, while 29 (32%) out of the 91 renal patients fell
out of the lower pole of the reference 95% tolerance ellipse.
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Fig. 3. 'RXc point graph" with the vector of the
average healthy subject plotted over the reference,
sex-specific 75% and 95% tolerance ellipses of
the healthy population. A. Males; B. females. R
is the resistance, Xc the reactance, and H the
height.
B C
Fig. 4. "RXc path graph" of three women. The shortest vector (left panel) was measured in a nephrotic patient with edema (A), undergoing remission
of proteinuria (B), with a subsequent relapse, due to tapering of the steroid (C), finally reaching her normal body composition after stable, complete
remission of proteinuria and full recovery of physical activity (D). The middle vector (middle panel) was measured in a patient with mild chronic renal
insufficiency, normal metabolic profile, body composition, and physical activity (a). Progressive renal failure caused a fluid overload (b), at first
controlled by diuretics (c), but finally requiring starting of chronic dialysis (d). The longest vector (right panel) was measured in a patient with acute
renal failure (ARF), caused by fluid loss. Renal function was restored after the impedance vector crossed back over the 75% tolerance ellipse, due to
large fluid infusion.
Moreover, 56 (62%) out of 91 renal patients fell out of the lower
pole of the 75% tolerance ellipse. Twenty-nine (32%) out of the
91 renal patients had apparent edema at the time of BIA
measurements. Twenty-eight (97%) of the 29 patients with appar-
ent edema fell out of the lower pole of the 75% tolerance ellipse,
of which 20 (69%) fell out of the lower pole of the 95% tolerance
ellipse. The fluid overload was heavier in those with shorter
down-sloping impedance vectors. One patient with apparent
edema fell within the lower pole of the 75% tolerance ellipse.
Seventeen (20%) of the 86 CS and 7 (18%) of the 40 OS fell out
of the 75% tolerance ellipse. Of these, 6 (7%) CS and 4 (10%) OS
fell out of the lower half of the 75% tolerance ellipse. Thus, the
lower pole of the sex-specific 75% tolerance ellipse was consid-
ered a bioelectrical impedance threshold for apparent edema in
renal patients.
In CRF patients, serum creatinine levels did not significantly
correlate with either R/H (r =
—0.18) or Xe/H (r = —0.21).
Plasma Na concentration was not correlated with either R/H (r =
0.02) or Xe/H (r = 0.11) in the CRF group. In the NS group it was
significantly correlated with RJH (r = 0.37, P = 0.03),but not with
Xe/H (r 0.22). In NS patients, plasma oncotic pressure was
linearly and significantly correlated with Xe/H (r 0.53, P <
0.001), but not with R/H (r 0.31). In CRF patients, oncotic
pressure did not correlate with either Xe/H or K/H (r =0.20, and
r = 0.01, respectively). Therefore, despite significant correlations,
the protocol variables possibly involved in extracellular fluid
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Table 1. Mean values with standard error (SCM), reported by sex and disease groups
CS CRF NS OS
Groups Males Females Males Females Males Females Males FemalesN 38 48 31 24 19 17 9 31 F0 Fsex F0
R/H, Ohm/rn
mean 292.6 374.3 268.1 340.4 247.2 289.7 231.6 301.5 183b 655b 11
SEM 7.6 9.7 8.7 10.5 9.4 17.2 10.2 7.7
Xe/H, Ohm/rn
mean 30.2 36.6 20.7 23.9 18.3 17.5 27.9 34.8 477& 116b 2.4
SCM 1.1 1.2 1.2 1.7 1.9 2.3 1.9 1.2
BMI, kg/rn2
mean 24.5 24.8 24.2 23.5 25.0 27.2 36.6 35.7 772b 0.1 1.3
SCM 0.5 0.5 0.4 0.9 0.8 1.0 1.7 0.8
Height, cm
mean 176.2 161.9 171.9 160.5 172.7 161.9 173.4 158.2
SEM 1.1 1.0 1.1 1.4 1.5 1.9 2.6 1.1
Abbreviations are: CS, healthy control subjects; CRF, chronic renal failure; NS, nephrotic syndrome; OS, obese subjects; R/H, resistance/height;
Xe/H, reactance/height.
F0, Fsex, and are F tests of the two-way ANOVA, for disease (D), sex and interaction effect.
ap < 0.05
<0.0001
2.8a 1538b 1.0
Table 2. Linear correlation coefficient (r) between the components
resistance/height (R/H) and reactance/height (Xc/H) of the impedance
vector
Groups CS CRF NS OS
Whole group N
r
P
86
0.477
<0.001
55
0.556
<0.001
36
0.667
<0.001
40
0.712
<0.001
Males N
r
P
38
0.323
0.048
31
0.508
0.004
19
0.736
<0.001
9
0.678
0.045
Females N
r
P
48
0.333
0.021
24
0.586
0.003
17
0.756
<0.001
31
0.637
<0.001
Values are given by sex and the following disease groups: CS, control
subjects; CRF, chronic renal failure; NS, nephrotic syndrome; OS, obese
subjects.
regulation accounted for less than 28% of the variability of either
impedance vector components, as indicated by the r2 values.
Discussion
When the aim is to compare the mean impedance vector of
groups of subjects, methods using the bivariate confidence inter-
vals are appropriate [101. Plotting data on a "RXc mean graph"
allows statistical testing and also easy interpretation of different
vector displacements (Figs. 1 and 2), since both the direction (that
is, the phase angle) and the magnitude of the impedance vector
are simultaneously considered. We could demonstrate a signifi-
cantly shorter impedance vector in both obese and renal patients
with respect to the healthy population (Fig. 1). Due to the
difference in the phase angle, BIA could discriminate between
obese and renal patients, but not between NS and CRF vector
displacements (Fig. 1). Because of the mutual correlation between
R and Xc, we are cautious in accepting that either individual
components of the impedance vector reflect changes in specific
fluid compartments [3, 11, 12]. We could not draw the confidence
ellipse for healthy populations reported in literature since neither
Xc measurements nor correlation between R and Xc have been
documented by gender. However, similar average values for both
R and Xc in distinctly different populations, that is, in a large
Italian population from a different region [13] and in Peruvians,
have been reported [6]. Data drawn from literature using the same
BIA technique and transformed onto the "RXc mean graph"
suggest that other clinical conditions characterized by fluid over-
load, such as cardiac surgery [5] and cirrhosis with ascites [14], are
characterized by average vector displacements as in renal patients
(Fig. 2).
To directly evaluate the fluid status of the individual patient by
BIA measurements, we must refer to the bivariate tolerance
intervals (tolerance ellipses) and thus use the confidence intervals
of mean vectors (confidence ellipses) as directional trends for the
interpretation of the single impedance vectors. Sex-specific toler-
ance ellipses (Fig. 3) appeared smaller in males than in females,
but still covered a large region of the RXc plane. This difference
can be accounted for by a greater variability in body composition
of either pre- or post-menopausal females over the wide age range
considered. However, when the aim is to compare the single
impedance vector of an individual subject with a reference
population, tolerance ellipses are required. Our "RXc point
graph" which uses tolerance ellipses corresponding to clinically
meaningful cut-off percentiles, allows straightforward interpreta-
tion of impedance vector placement. Since the vectors of renal
patients covered a plane region less than 1/5 of the tolerance
ellipses, close to the lower poles, less than 1% and 5% of the
healthy population were expected (and observed) to overlap out
of the lower poles of the 95% and 75% tolerance ellipses,
respectively (Appendix). However, the probability distribution
calculated on larger samples could be represented by smaller
ellipses, and populations of different races might yield different
shape and sizes for sex-specific ellipses.
Monitoring of fluid overloading or removal in the single patient
is immediate with the "RXc path graph." It allows direct compar-
ison of intrasubject (analytical, physiological and pathological
components) with intersubject variability. As depicted in Figure 4,
while a progressive shortening and down-sloping of the imped-
ance vector over successive measurements indicates progressive
fluid overloading, a progressive lengthening and steepening of the
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vector indicates fluid removal. A body fluid variation in both
directions in the same patient causes a symmetric backward and
forward shift of the vector on the RXc plane (Fig. 4). Therefore,
the aim of therapy is to bring the individual vector back into the
75% tolerance ellipse towards the reference target point (that is,
the crossing of the reference, sex-and-race specific ellipse axes), or
better to a previously recorded healthy target point for that
patient. As a working hypothesis, we believe that a progressive
shortening and down-sloping of the impedance vector could
correspond to a progressive shift to the right of the interstitial
pressure-volume curve [41, whose sudden increase in the slope
(positive pressure with the appearance of free fluid and edema)
could occur when the impedance vector falls out of the lower pole
of the 75% tolerance ellipse. The intra-subject variation of the
interstitial negative pressure (gel hydration) could be described by
impedance vector displacement within the 75% tolerance ellipse
before clinically detectable fluid volume variation. The impedance
vectors of patients falling out of the upper 95% and 75% poles of
the tolerance ellipses indicate dehydration (Fig. 4, ARF vector),
also clearly shown after the transformation of the measurements
obtained in cholera dehydration [6] onto the 'RXc mean graph"
(Fig. 2). Since our study was designed to find BIA thresholds for
fluid overload, the relationship between BIA and dehydration
requires further investigation.
Most obese patients fell within the left half of the 75%
tolerance ellipse. Interestingly, an increased ratio of extracellular
to intracellular water in obesity [151 and mean impedance values
for obese females close to ours [16] have been reported in
literature (Fig. 2). Extremes of lean body mass such as in athletes
[17] or wasting conditions, such as AIDS [18] and anorexia
nervosa [191, do not show a shortening of vectors with respect to
CS group, but a displacement either upward or downward,
respectively (Fig. 2). These observations can open new horizons
for the use of the RXc graphs in monitoring the body composition
and the nutritional status of patients with or without fluid
disorders [20].
We used the conventional, whole-body BIA measurement
(tetrapolar, with 50 kHz stimulation frequency) which reflects
total body water with the best accuracy required for clinical
evaluation and with a greater history of validation [1—3, 5, 6, 8, 11,
15, 21—25], but the RXc graph method might yield better results
with different BIA techniques, in particular combining multifre-
quency with different electrodes placements [26—281. However,
following the traditional BIA approach, where the accuracy of
formulae predicting the volume of total body water and the
fat-free mass is significantly improved by the inclusion of variables
such as weight, age, and sex in addition to the impedance index
H2/R [1, 2], the user should be familiar with the equation supplied
by the manufacturer of the impedance analyzer and know which
"gold standard" body composition technique and reference pop-
ulation were used to generate the equation. Operating with the
RXc graphs only requires plotting direct RIH and Xc/H measure-
ments on the reference population distribution, which allows one
to decide whether a patient has maintained normal hydration
forfeiting prediction of total body water in liters. If the former
estimates of volume and mass are of interest, and the patient's
impedance vector lies within the 75% tolerance ellipse, the
traditional prediction formulae can be applied with confidence.
Until now we have considered steady-state conditions but pilot
studies indicate a useful application of our RXc graph method in
dynamic situations as well, when fluid is removed (dialysis, and
extracorporeal ultrafiltration) or infused (hydration and total
parenteral nutrition). Indeed, rigorous studies are necessary to
establish the correspondence between impedance vector displace-
ment over the RXc plane and subtle body fluid variation. The
greatest potential use of the method might be in those patients in
whom baseline impedance vectors (at least 10 points, to achieve
reasonable tolerance intervals) have already been measured in the
healthy condition, so that subsequent changes away from their
own smaller tolerance ellipses might be significant even if they
remained within the reference population 75% tolerance ellipse.
In conclusion, we found a bioimpedance threshold for fluid
overload and a useful innovative graphical method for identifica-
tion, monitoring and therapy planning of renal patients with
altered fluid balance using direct bioimpedance measurements
and following a new bivariate vectorial approach. Further rigorous
studies are necessary to define whether the method proves to be
generally applicable to a variety of different clinical situations.
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Appendix
For readers less familiar with multivariate analysis, we report the basic
definitions of multivariate confidence and tolerance intervals as well as
formulae for their calculations in the particular case of the assumption of
the bivariate normal distribution for the RXc graph.
Confidence interval is the inferential statistical interval for a given
parameter (such as a mean value) investigated. It is the region in the
parameter space to which is assigned the probability 100(1 — a)% (a is
some fixed probability, typically 0.05) that the parameter vector lies within.
The confidence interval of the mean of the univariate normal distribution
is formed by two values (limits), while the interval of the mean vector of
the multinormal distribution is an ellipsoid centered at the mean vector,
which reduces to a hypersphere when the correlation coefficients between
pairs of variables are zero. When the confidence ellipsoids of two mean
vectors overlap, the null hypothesis of equality of the two mean vectors
cannot be rejected with the significance level a. The 95% confidence
ellipses of several impedance mean (bivariate) vectors are depicted in
Figure 1.
Tolerance interval is the probability interval within which a specified
proportion of a distribution (such as a population) will lie with a fixed
probability 100(1 — a)%. The a values are selected for the particular
descriptive or inferential purposes, typically ranging from 0.5 (median),
0.75 (third quartile), to 0.95 or 0.99 (95th or 99th percentiles). Such
interval can be used to decide whether particular observations (individual
vectors) are from the same population as a previous sample, used to
determine the interval. The tolerance intervals of the multinormal distri-
bution are ellipsoids (contours of equal concentrations centered at the
mean vector), which reduce to hyperspheres when the correlation coeffi-
cients between pairs of variables are zero. Figure 3 depicts the 75% and
95% tolerance ellipses for our healthy population. Since 25% and 5% of
observations are expected to lie out of the 75% and 95% tolerance
ellipses, respectively, 6.3% and 1.2% are expected to lie out of the contour
of the four ellipses' quadrants, and 5% and 1% will lie out of a 1/5
partition of the ellipses' contour (for example, the lower pole).
Both the confidence and tolerance intervals become smaller with
increasing sample size. But, in a very large population (such as multinor-
mal), while the confidence interval converges to the parameter vector (for
example, the mean vector point), the tolerance interval converges to the
interval corresponding to the quantiles of the population within which lies
the percentage of the (infinite) population to which the tolerance interval
relates (such as the ellipsoid for the particular a value).
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Calculations. In the case of the bivariate normal distribution, both
approximate and exact methods are available for calculations of both
confidence and tolerance ellipses [29]. We present our modified version of
the exact methods using common statistics of the simple linear correlation
analysis. Given n pairs of observations x and y, with standard deviations s,
and 5) and correlation coefficient r, one must fix the a probability level and
take the Snedecor's F value with 2 and n-2 degrees of freedom. The
semi-axes L1 and L2, and the slopes b1 and b2 = — 1/b1, of the axes of the
100(1 — a)% confidence and tolerance ellipses can be calculated using
equations (1) and (2), respectively.
L1, = K(n— 1)(2 + 2) [(n - 1)(2 + 2)]2 — 4(n— 1)2(1 - 2)22
where
K = FIn(n — 2) for confidence ellipsesK = F(n + 1)In(n — 2) for tolerance ellipses
b, — 1/b = (2 — 2)/ I + [(2 —
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